This hypothesis is supported by the clinical observation that AURKA overexpression is correlated with p53 mutation in hepatocellular carcinomas, and that tumors with both AURKA overexpression and p53 mutation have a worse prognosis than those with p53 mutation alone (42). The gene discussed is TP53; the disease is hepatocellular carcinoma.